References:

• Fujiwara Y et al.  Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese
  version of the Montreal Cognitive Assessment.  Geriatr Gerontol Int. 2010;10:225-232.
• Park J et al.  The validity of the Korean-Montreal Cognitive Assessment (K-MoCA) as a screening test for both
  MCI and VCI.  Conference abstract presented at the 20th Annual Rotman Research Institute Conference,
  The frontal lobes, Toronto, Canada, March 22-26, 2010.
• Guo Qi-Hao et al.  Application study of quick cognitive screening test in identifying mild cognitive impairment.
  Neuroscience Bulletin Feb. 2010, 26 (1): 47:54.
• Manuel Montero-Odasso, Susan W. Muir.  Simplifying detection of mild cognitive impairment subtypes. 
  Journal of the American Geriatrics Society, May 2010-Vol. 58, no. 5.
• Cameron J. et al.  Does cognitive impairment predict poor self-care in patients with heart failure?  European Journal
  of Hearth failure (2010) 12, 508-515.
• Walter Wittich, Natalie Phillips, Ziad Nasreddine, Howard Chertkow.  Sensitivity and specificity of the Montreal
  Cognitive Assessment modified for individuals who are visually impaired.  Journal of Visual Impairment & Blindness,
  104(6), 360-368, June 2010.
• Sarah H. et al.  Pilot study of a three-step diagnostic pathway for young and old patients with Parkinson's disease
  dementia: screen, test and then diagnose.  International Journal of Geriatric Psychiatry 2010; 25: 258-265.
• Sarah T. Pendlebury et al.  Underestimation of Cognitive Impairment by Mini-Mental State Examination Versus
  the Montreal Cognitive Assessment in Patients with Transient Ischemic Attack and Stroke.  A Population-Based Study.
  Stroke Journal of the American Heart Association, 41(6):1290-1293, June 2010.
• Gagnon JF. et al.  The Montreal Cognitive Assessment: A Screening Tool for Mild Cognitive Impairment in REM
  Sleep Behavior Disorder.  Movement Disorders 2010, online e-pub before paper.
• Videnovic A., et al.  The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's
  disease.  Movement Disorders, 2010: 25 (3): 401-4.
• Olson R., Parkinson M., McKenzie M.  Selection Bias Introduced by Neuropsychological Assessments.  Canadian
  Journal of Neurological Sciences, 2010; 37: 264-268.
• Lessig S. et al.  Usefulness of Two Brief Cognitive Screening Measures in Huntington's Disease.  Poster.
  Neurotherapeutics, Vol. 7, No 1, 2010, Page 139.
• Hoops S et al.  Validity of the MoCA and MMSE in the detection of MCI and dementia in
  Parkinson disease.  Neurology 2009 Nov. 24 ; 73(21):1738-1745.
• Copersino ML et al.  Rapid cognitive screening of patients with substance use disorders. 
  Experimental and Clinical Psychopharmacology 17(5): 337-344, 2009.
• Duro D et al.  Validation studies of the Portuguese experimental version of the
  Montreal Cognitive Assessment (MoCA): confirmatory factor analysis.  J. Neurol. 2009, Nov. 25 (epub ahead of print).
• Rolf Sebaldt, William Dalziel, Fadi Massoud, André Tanguay, Rick Ward, Lehana Thabane,
  Peter Melnyk, Pierre-Alexandre Landry, Benedicte Lescrauwaet.  Detection of Cognitive Impairment and Dementia
  Using the Animal Fluency Test: The Decide Study, The Canadian Journal of Neurological Sciences, Volume 36,
  issue 5, Sept. 2009, page 599.
• Ging-Yuek R. Hsiung et al.  A Pilot Study on Computerized Cognitive Training in Mild Cognitive Impairment. 
  5th Canadian Conference on Dementia in Toronto, Oct. 1-3 2009.  The Canadian Journal of Geriatrics, Volume 12, 
  issue 3, September 2009, page 124.
• A. Garcia et al.  Apathy in Dementia: Are we detecting it? 5th Canadian Conference on Dementia in Toronto,
  Oct. 1-3 2009.  The Canadian Journal of Geriatrics, Volume 12, issue 3, September 2009, page 121.
• Lisa Sweet, phd et al.  The Montréal Cognitive Assessment (MoCA) in Geriatric Rehabilitation: Psychometric
  Properties and Association with Rehabilitation Outcomes.  5th Canadian Conference on Dementia in Toronto,
  Oct. 1-3 2009.  The Canadian Journal of Geriatrics, Volume 12, issue 3, September 2009, page 113.
• Bejamin Lam et al.  Validation of the Montreal Cognitive Assessment against Detailed Neuropsychological Measures. 
  5th Canadian Conference on Dementia in Toronto, Oct. 1-3 2009.  The Canadian Journal of Geriatrics, Volume 12,
  issue 3, September 2009, page 138.
• Hemrungrojn S et al.  The cognitive domains from Thai-Montreal cognitive assessment test to discriminate between
  amnestic MCI and mild AD from normal aging. Presented at the International Psychogeriatric Association Conference,
  September 2009, Montreal, Quebec, Canada.
• Tangwongchai S et al.  The Validity of Thai version of The Montreal Cognitive Assessment (MoCA-T), Presented at the
  International Psychogeriatric Association Conference, September 2009, Montreal, Quebec, Canada.
• Janneke Thissen et al. Validity of the Montreal Cognitive Assessment Dutch Version (MoCA-D), Presented at the
  International Psychogeriatric Association Conference, September 2009, Montreal, Quebec, Canada.
• Adrian Wong et al.  The Validity, Reliability and Clinical Utility of the Hong Kong Montreal Cognitive Assessment
  (HK-MoCA) in Patients with Cerebral Small Vessel Disease, Dement Geriatr Cogn Disord Aug. 2009;28:81-87.
• Olson R, Iverson G, Parkinson M, Carolan H, Ellwood A, McKenzie M. Investigation of cognitive screening measures in
  patients with brain tumors: diagnostic accuracy & correlation with quality of life.  2009 American Society of Clinical
  Oncology Annual Meeting.  Orlando, Florida.  May 29-June 2, 2009.  Abstract ID: e13000.
• Olson R, Iverson G, Parkinson M, Carolan H, Ellwood A-L, McKenzie M. Comparison of the Mini Mental State
  Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) to a Comprehensive Neuropsychological
  Assessment in Patients with Brain Tumors.  11th World Congress of Psycho-Oncology.  Vienna, Austria. 
  June 21-25, 2009. Abstract P3.7.17
• Olson R, Ellwood A-L, Parkinson M, Carolan H, Ferguson K, Iverson G, McKenzie M.  
  Comparison of Two Cognitive Screening Measures, the Mini Mental State Examination
  (MMSE) and the Montreal Cognitive Assessment (MoCA), in Patients with Brain Tumors. 
  Canadian Association of Psychosocial Oncology, 2009 Conference.  Vancouver, 
  British Columbia.  April 1-4, 2009.  Abstract ID: P245.
• JL Richard, LL Boyle, MS Ismail, X Tu.  Use of the MOCA in Patients Presenting to a  Memory Disorders Clinic.  
  Am J Geriatr Psychiatry 2009; 17:A112.
• Rahman, Tomader Taha Abdel;El Gaafary, Maha Mohamed.  Montreal Cognitive Assessment Arabic version:
  Reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo.
  Geriatrics and Gerontology International, Vol. 9, Number 1, March 2009, pp. 54-61 (8).
• Irak-Dersu I, Bond C, Evans M, Grigorian P, Spencer H.  Effect of dilating drops on cognitive function.  Presented at
  35th annual North American Neuro-ophthalmology meeting, February 24, 2009, Lake Tahoe, Nevada.
• Irak-Dersu I, Bond C, Evans M, Grigorian P, Spencer H.  The Effect of Mydriatic Eye Drops on Cognitive Function in
  Claucoma Patients.  Presented at 19th annual American Glaucoma Society meeting, March 6, 2009, San Diego, CA.
• Sarra et al. Montreal Cognitive Assessment Performance in Patients with Parkinson's Disease with  “Normal” Global
  Cognition According to Mini-Mental State Examination Score. J Am Geriatr Soc Vol 57, Num 2,  February 2009, 
  pp. 304-308(5).
• Corey-Bloom J. et al. A Comparison of Two Brief Cognitive Instruments in Huntington Disease (HD). Poster
  presentation. Neurotherapeutics, Vol 6, Issue 1, Page 206  (January 2009).
• Wong A. et al. The Validity, Reliability and Utility of the Cantonese Montreal CognitiveAssessment (MoCA) in Chinese
  Patients with Confluent White Matter Lesions. Hong Kong Med J Vol 14 No 6 # Supplement 6 #, December 2008.
• Luis CA, et al. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in
  the Southeastern US. International Journal of Geriatric Psychiatry, Online issue, October 21st, 2008, published
  2009;24: 197-201.
• Lessig S. et al. Examination of the Montreal Cognitive Assessment (MoCA) and MMSE in Parkinson's disease (PD). 
  Abstract T-82. Presented at American Neurological Association Meeting, Salt Lake City, Utah, September 24th, 2008.
• Joanna Magierska, Radoslaw Magierski, Tomasz Sobow, Iwona Kloszewska.  The Polish adaptation of the Montreal
  Cognitive Assessment (MoCA) and preliminary results of its clinical utility in the screening for cognitive impairment. 
  Poster presented at the ICAD Conference, 2008.
• K. Waspe, G. Vorobeychik, N. Beauregard Evaluation of Modified Montreal Cognitive assessment in multiple
  sclerosis:  a pilot study. Multiple Sclerosis, 2008; 14(supp 1) p. S29. Presented at ECTRIMS meeting, Montreal,
  Sept. 2008.
• Bertolucci PH et al. Brazilian Portuguese version for the Montreal Cognitive Assessment (MoCA) and the preliminary
  results. Presented at Alzheimer's Association International Conference on Alzheimer's Disease. Alzheimer's and
  Dementia Vol 4, Issue 4, Supplement 1, July 2008, Page T686.
• Song S et al. Executive impairment and MoCA performance in mild cognitive impairment and Alzheimer's disease.
  Presented at the International Neuropsychological Society Annual Meeting. Buenos Aires, Argentina. 
  July 2-5 2008, p 258.
• Jun-Young Lee et al. Brief Screening for Mild Cognitive Impairment in Elderly Outpatient
  Clinic: Validation of the Korean Version of the Montreal Cognitive Assessment. 2008;
  J Geriatr Psychiatry Neurol June 2008, 21;2:104-110.
• Boulanger JM et al. A prospective cognitive evaluation in post stroke/TIA patients using the
  Montreal Cognitive Assessment test (MoCA) . Presented at Nice, France. European Stroke Conference, May 2008.
• Johns, EK et al. The effect of education on performance on the Montreal Cognitive Assessment
  (MoCA):  Normative data from the community. The Canadian Journal of Geriatrics, 11, 32-73. [Poster presented at the
  28th  annual meeting of the Canadian Geriatrics Society, Montreal, QC, April 2008.
• Ratchford TL, et al. Normative Data for the Montreal Cognitive Assessment (MoCA) in Young Adults.  P05.128. 
  Presented at the American Academy of Neurology Meeting.  April 2008. Neurology 70 March 11, 2008 (Suppl 1) A283.
• Gill DJ et al. The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's
  disease. Mov Disorders, Volume 23, Issue 7, 2008.
• Ponrathi Athilingam. The Montreal Cognitive Assessment (MoCA): An appropriate tool to assess subtle cognitive
  changes in people with heart failure? Section: "Innovations in Nursing Practice with Older Adults".  Presented at the
  ENRS 20th scientific conference. Philadelphia, March 27 th, 2008.
• Olson RA et al. Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases. 
  0941-4355 (Print) 1433-7339 (Online) Supportive Care in Cancer. Wednesday,  March 12, 2008, 16:1273-1278
• Nestor SM et al. The Montreal Cognitive Assessment: a retrospective pilot study measuring longitudinal cognitive
  change in people with mild cognitive impairment. Presented at the Annual Meeting of the Canadian Geriatrics
  Society, Montreal Canada, Canadian J of Geriatrics Vol 11, Issue 1,   March 2008, p63.
• Koski L. et al. Measuring Cognition in a Geriatric Outpatient Clinic: Rasch Analysis of the Montreal Cognitive
  Assessment. Journal of Geriatric Psychiatry and Neurology, Vol 22, No 3, Sept. 2009, Page 151-160.
• Smith M, et al. Case finding of people with cognitive impairment using screening clinics during Alzheimer
  awareness month. Presented at the Annual Meeting of the Canadian Geriatrics Society, Montreal Canada,
  Canadian J of Geriatrics Vol 11, Issue 1, March 2008, p37.
• Johns, EK et al. The Montreal Cognitive Assessment: Normative data in the community.  Journal of the International
  Neuropsychological Society, 14(Suppl. 1), i-292. [Poster presented at the 36th annual meeting of the International
  Neuropsychological Society, Waikoloa, Hawaii, February 2008].
• Zadikoff C et al. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying
  cognitive deficits in Parkinson's disease. Mov Disord.  2008 Jan 30;23(2):297-9.
• Wen HB et al. The application of Montreal cognitive assessment in urban Chinese residents of Beijing. Zhonghua Nei
  Ke Za Zhi. 2008 Jan;47(1):36-9. Chinese.
• Tobinick et al. Rapid cognitive improvement in Alzheimer’s disease following perispinal etanercept administration.
  J of Neuroinflammation January 2008, 5:2 (e-publication, paper publication to come).
• Shiroky et al. Can you have dementia with an MMSE score of 30. Am J of Alzeimers Dis Other Demen
  Oct-Nov 2007;22:5;406-415.
• Chertkow H, Nasreddine Z, Joanette Y, Drolet V, Kirk J, Massoud F, Belleville S, Bergman H. Mild
  cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis
  Alzheimer's & Dementia: The Journal of the Alzheimer's Association October 2007  
  (Vol. 3, Issue 4, Pages 266-282).
• Howe E. Initial screening of patients for Alzheimer's disease and minimal cognitive impairment.
  Psychiatry.  Vol 4(7) Jul 2007, 24-27.
• Holsinger et al. Does this patient have dementia? JAMA, June 6, 2007-Vol 297, No 21;2391-2404.
• Smith T et al. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J
  Psychiatry. 2007 May; 52(5):329-32.
• Martinić Popović I. et al. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease
  Journal of the Neurological Sciences Volume 257, Issues 1-2, 15 June 2007, Pages 185-193.
• Hachinski et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive
  impairment harmonization standards. Stroke. 2006, Sep;37(9):2220-41. Epub 2006 Aug 17.
• Gauthier et al. Mild cognitive impairment. Lancet. 2006 Apr 15;367(9518):1262-70. Review.
• J. Reban. Montrealsky kognitivni test /MoCA/: přínos k diagnostice predemencí, Česká Geriatrická Revue 2006 
  (4):224-229.
• Martinic-Popovic I. et al. Early detection of mild cognitive impairment in patients with cerebrovascular disease.
  Acta Clin Croat 2006;45:77-85.
• Allan L et al. Mild Cognitive Impairment: An Opportunity to Identify Patients at High Risk for Progression to
  Alzheimer's Disease. Clin Ther 2006;28:991-1001.
• Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H.  
  The  Montreal Cognitive Assessment (MoCA): A Brief Screening Tool For Mild Cognitive Impairment. J Am Geriatr
  Soc   53:695–699, 2005.
• Nasreddine ZS, Chertkow H, Phillips N, Whitehead V, Collin I, Cummings JL. The Montreal Cognitive
  Assessment (MoCA): a Brief Cognitive Screening Tool for Detection of Mild Cognitive Impairment. Neurology Vol 62
  No 7 S(5) April 2004 A132. Presented at the American Academy of Neurology Meeting, San Francisco, May 2004.
• Nasreddine ZS, Chertkow H, Phillips N, Whitehead V, Bergman H, Collin I, Cummings JL,  Hébert L.
  The Montreal Cognitive Assessment (MoCA): a Brief Cognitive Screening Tool for Detection of Mild Cognitive
  Impairment. Presented at the 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy. 
  http://www.siumed.edu/cme/AlzBrochure04.pdf p. 90, April 14-17, 2004.
• Nasreddine ZS, Collin I, Chertkow H, Phillips N, Bergman H, Whitehead V. Sensitivity and Specificity of The Montreal
  Cognitive Assessment (MoCA) for Detection of Mild Cognitive Deficits. Can J Neurol Sci Volume 30, Number 2
  Supplement 2/May 2003 p 30. Presented at Canadian Congress of Neurological Sciences Meeting, Québec City,
  Québec, June 2003.